PCV3- AN ANALYSIS OF THE COST OF ADVERSE EVENTS ASSOCIATED WITH THE USE OF HMG-COA REDUCTASE INHIBITORS
Sep 1, 2001, 00:00
10.1046/j.1524-4733.2001.40202-77.x
https://www.valueinhealthjournal.com/article/S1098-3015(11)71236-0/fulltext
Title :
PCV3- AN ANALYSIS OF THE COST OF ADVERSE EVENTS ASSOCIATED WITH THE USE OF HMG-COA REDUCTASE INHIBITORS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71236-0&doi=10.1046/j.1524-4733.2001.40202-77.x
First page :
Section Title :
Open access? :
No
Section Order :
128